NCT03317262View on ClinicalTrials.gov

Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIon

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
DepressionAnxiety Disorders
Trial Locations (1)

Unknown

Private Office, Larissa

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY

NCT03317262 - Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIon | Biotech Hunter | Biotech Hunter